Vimarsana
Biggest News Aggregation in the World

Page 25 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Studies Today - Breaking & Trending Today

WHO Offers Recommendations for AI Guidelines in Healthcare - Vimarsana News

WHO Offers Recommendations for AI Guidelines in Healthcare

Experts emphasize the importance of training AI systems on reliable data and of checking the systems’ safety and efficacy.

Genetic Therapies Bring Change to Neurology Clinics - Vimarsana News

Genetic Therapies Bring Change to Neurology Clinics

New therapies are on the horizon for genetic neuromuscular diseases, and this will raise both hopes for patients and challenges for neurologists.

Newer Antiobesity Meds Lower the Body's Defended Fat Mass - Vimarsana News

Newer Antiobesity Meds Lower the Body's Defended Fat Mass

Newer antiobesity medications change the body's defended fat mass (set point) to something more normal, rather than "fixing" it at a lower target, which is a good thing, says a clinician.

Test All Perinatally Exposed Infants for HCV: CDC - Vimarsana News

Test All Perinatally Exposed Infants for HCV: CDC

HCV infection, which can lead to liver fibrosis and cirrhosis, liver failure, hepatic cancer, and transplant, will develop in 6%-7% of all perinatally exposed infants and children.

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript - Vimarsana News

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript November 3, 2023 Oncolytics Biotech Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.07. Operator: Good morning, and welcome to Oncolytics Biotech’s Third Quarter 2023 Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the […]

Source: yahoo.com